छोड़कर सामग्री पर जाएँ

Dr Reddy#39;s drops 4% after being named in US anti-trust lawsuit

The complaint accuses Dr Reddy#39;s of improperly restraining competition and maintaining a monopoly in the sale of the cancer drug Revlimid

Read More

​ The complaint accuses Dr Reddy#39;s of improperly restraining competition and maintaining a monopoly in the sale of the cancer drug Revlimid The complaint accuses Dr Reddy#39;s of improperly restraining competition and maintaining a monopoly in the sale of the cancer drug Revlimid  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी